| Literature DB >> 33805635 |
Raffaele Pugliese1, Anna Arnoldi2, Carmen Lammi2.
Abstract
Naturally occurring food peptides are frequently used in the life sciences due to their beneficial effects through their impact on specific biochemical pathways. Furthermore, they are often leveraged for applications in areas as diverse as bioengineering, medicine, agriculture, and even fashion. However, progress toward understanding their self-assembling properties as functional materials are often hindered by their long aromatic and charged residue-enriched sequences encrypted in the parent protein sequence. In this study, we elucidate the nanostructure and the hierarchical self-assembly propensity of a lupin-derived peptide which belongs to the α-conglutin (11S globulin, legumin-like protein), with a straightforward N-terminal biotinylated oligoglycine tag-based methodology for controlling the nanostructures, biomechanics, and biological features. Extensive characterization was performed via Circular Dichroism (CD) spectroscopy, Fourier Transform Infrared spectroscopy (FT-IR), rheological measurements, and Atomic Force Microscopy (AFM) analyses. By using the biotin tag, we obtained a thixotropic lupin-derived peptide hydrogel (named BT13) with tunable mechanical properties (from 2 to 11 kPa), without impairing its spontaneous formation of β-sheet secondary structures. Lastly, we demonstrated that this hydrogel has antioxidant activity. Altogether, our findings address multiple challenges associated with the development of naturally occurring food peptide-based hydrogels, offering a new tool to both fine tune the mechanical properties and tailor the antioxidant activities, providing new research directions across food chemistry, biochemistry, and bioengineering.Entities:
Keywords: antioxidant activity; bioactivity; lupin peptides; mechanical properties; nano-nutraceuticals; rheology; self-assembling peptides; supramolecular hydrogels
Year: 2021 PMID: 33805635 PMCID: PMC8000348 DOI: 10.3390/biomedicines9030294
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Supramolecular organization of T13 and BT13 peptide solutions. (a) Circular dichroism (CD) spectra of T13 (in blue) and BT13 (in red) suggesting the presence of β-sheet secondary structures. (b) FT-IR spectra of T13 and BT13 peptides with a characteristic β-hairpin conformation for T13, and typical anti-parallel β-sheet conformation for BT13 peptide. (c) ThT-binding assay of T13 and BT13 peptides, showing a high amyloid-binding emission signal (centered at 490 nm) of BT13 compared to T13 peptide.
Figure 2Morphological organization of T13 and BT13 peptide nanostructures. Atomic force microscopy images of (a) T13 and (b) BT13 peptides. Orientation distribution of (c) T13 and (d) BT13 peptides showing that the N-terminal biotin tag triggers a disorder-to-order transition in the BT13 assemblies. Scale bar, 500 nm.
Figure 3Rheological studies to evaluate the mechanical properties of BT13 hydrogels. Frequency-dependent oscillatory rheology (0.1–100 Hz) of (a) T13 and (b) BT13 peptides at 0.5%, 1%, and 3% (w/v). (c) Average values of storage (G’) and loss moduli (G’’) of T13 and BT13 peptides at 0.5%, 1%, and 3% (w/v). (d) Thixotropy test of BT13 hydrogel.
Figure 4In vitro antioxidant power evaluation of BT13 by DPPH assay. The data points represent the means ± SD of four independent experiments in triplicate. Data were statistically analyzed by one-way ANOVA followed by Tukey’s post-hoc test. (*) p < 0.5; (**) p < 0.1; (***) p < 0.001. ns: not significant; C: control sample.
Screening of the T13 activity using BIOPEP database (www.uwm.edu.pI/biochemia). T13 Peptide sequence: LNALEPDNTVQSEAGTIETWNPK.
| Activity | Sequence Motif |
|---|---|
| ACE inhibitor | AG |
| GT | |
| IE | |
| LN | |
| EA | |
| ALEP | |
| DPP-IV inhibitor | EP |
| NP | |
| AL | |
| WN | |
| AG | |
| DN | |
| ET | |
| LN | |
| NA | |
| NT | |
| PK | |
| QS | |
| TW | |
| WQ | |
| TI | |
| Antioxidant | TW |
| Alpha-glucosidase inhibitor | EA |
ACE: angiotensin-converting enzyme; DPP-IV: dipeptidyl peptidase-IV.